Physician
Sharma, Malvika
Sharma, Malvika was paid $358K by Medicaid between Jan 2020 and Dec 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoSHARMA, MALVIKA
DAMASCUS, MD 20872
DAMASCUS, MD 20872
33aNPI1225193493assigned 12/27/2006
33bProvider typePediatrics Physician
28Total paid$358K
24GClaims7,441
24DCodes billed24
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#130 of 306
Median peer was paid$206K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 868 | $40K | |
| 2021 | 1,479 | $64K | |
| 2022 | 2,462 | $115K | |
| 2023 | 1,589 | $84K | |
| 2024incomplete | 1,043 | $56K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 1,895 | 1,534 | $158K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 1,206 | 1,027 | $140K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.4% | 973 | 850 | $9K |
| 90686 | 2.0% | 322 | 292 | $7K | |
| 87428 | 1.6% | 155 | 135 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 52 | 45 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 108 | 75 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 108 | 98 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 32 | 25 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 287 | 245 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 61 | 59 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 25 | 24 | $3K |
12 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 318 | $3K |
| 92552 | <1% | 89 | $2K | |
| 92551 | <1% | 201 | $2K | |
| 96127 | <1% | 320 | $1K | |
| 94760 | <1% | 617 | $1K | |
| 87807 | <1% | 94 | $827.48 | |
| 90656 | <1% | 29 | $675.12 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 49 | $488.00 |
| 99173 | <1% | 177 | $451.92 | |
| 99072 | 0% | 268 | $0.00 | |
| 99000 | 0% | 42 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.